What is Royalty Pharma's jnj‑4804 — total commitments?

Royalty Pharma (RPRX) reported jnj‑4804 — total commitments of $500.00M in Q1 2026.

What does jnj‑4804 — total commitments mean?

The total amount of capital the company has committed to invest in the JNJ-4804 royalty asset.

Products & Services · Total Commitments

JNJ‑4804 — Total Commitments

Analysis

StatementSegment

CategoryCapital Allocation

SignalContext dependent

VolatilityStable

First reportedQ1 2026

Last reportedQ1 2026

Rolls up toTotal Commitments

How to read this metric

An increase indicates a larger capital allocation or expanded investment scope in the asset, while a decrease suggests a reduction in total commitment, potentially due to asset maturity or divestment.

Detailed definition

This metric represents the aggregate contractual obligation or total capital commitment allocated by the firm toward the...

Peer comparison

Comparable to total investment commitments or gross asset acquisition costs reported by other royalty-based investment firms or specialty finance companies.

Metric ID: rprx_segment_jnj_4804_total_commitments

Historical Data

1 periods

	Q1 '26
Value	$500.00M

Similar Metrics at Other Companies

FirstEnergyFE View metric

Natera, Inc.NTRA View metric

Johnson & JohnsonJNJ View metric

Roivant SciencesROIV View metric

Ares Management CorporationARES View metric

Frequently Asked Questions

What is Royalty Pharma's jnj‑4804 — total commitments?: Royalty Pharma (RPRX) reported jnj‑4804 — total commitments of $500.00M in Q1 2026.
What does jnj‑4804 — total commitments mean?: The total amount of capital the company has committed to invest in the JNJ-4804 royalty asset.